Xpert MTB/RIF and GenoType MTBDRplus assays for the rapid diagnosis of bone and joint tuberculosis

Xpert MTB/RIF and GenoType MTBDRplus assays for the rapid diagnosis of bone and joint tuberculosis

Background: Bone and joint tuberculosis (BJTB) constitutes about 10–20% of the extrapulmonary tuberculosis (EPTB) cases in China. The GenoType MTBDRplus assay (MTBDR) has been endorsed by the World Health Organization (WHO) for the diagnosis of pulmonary TB (PTB), while the Xpert MTB/RIF assay (Xper...

Full description

Bibliographic Details
Main Authors:	Yunting Gu, Guirong Wang, Weijie Dong, Yunxu Li, Yifeng Ma, Yuanyuan Shang, Shibing Qin, Hairong Huang
Format:	Article
Language:	English
Published:	Elsevier 2015-07-01
Series:	International Journal of Infectious Diseases
Subjects:	Bone and joint tuberculosis Xpert MTB/RIF GenoType MTBDRplus
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971215001228

Similar Items

Use of Xpert MTB/RIF for diagnosis of pediatric tuberculosis in Indonesia
by: Rina Triasih, et al.
Published: (2020-07-01)

Implementation of the Xpert MTB/RIF assay for tuberculosis in Mongolia: a qualitative exploration of barriers and enablers
by: Nicole L. Rendell, et al.
Published: (2017-07-01)

The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda
by: A. Andama, et al.
Published: (2021-01-01)

A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China
by: Xichao Ou, et al.
Published: (2015-02-01)

The occurrence of a multidrug-resistant tuberculous retropharyngeal abscess in an immunocompetent patient: A case report
by: N. Tiresse, et al.
Published: (2021-01-01)

Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis
by: Nhu Nguyen Thi Quynh, et al.
Published: (2013-01-01)

Utility of Xpert MTB/RIF Assay for Diagnosis of Pediatric Tuberculosis Under Programmatic Conditions in India
by: Rakesh Yadav, et al.
Published: (2020-01-01)

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
by: Yeliz Tanriverdi Cayci, et al.

Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
by: Suraj Kumar, et al.
Published: (2017-04-01)

Performance of Xpert® MTB/RIF in detecting Multidrug-Resistance Tuberculosis in West Java, Indonesia
by: Edhyana Sahiratmadja, et al.
Published: (2020-06-01)

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
by: Julia V. Ershova, et al.
Published: (2020-07-01)

Rapid diagnosis of pleural tuberculosis by Xpert MTB/RIF assay using pleural biopsy and pleural fluid specimens
by: Jinghui Du, et al.
Published: (2015-01-01)

The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia
by: Diriba K, et al.
Published: (2021-09-01)

Diagnostic accuracy of the Xpert MTB/RIF assay for bone and joint tuberculosis using tissue specimens
by: Zibo Zhou, et al.
Published: (2021-04-01)

Difficulties with the implemented xpert MTB/RIF for determining diagnosis of pulmonary and extrapulmonary tuberculosis in adults and children
by: Ni Made Mertaniasih, et al.
Published: (2020-05-01)

Diagnostic accuracy of GeneXpert MTB/RIF in musculoskeletal tuberculosis: High sensitivity in tissue samples of HIV-infected and HIV-uninfected patients
by: M Held, et al.
Published: (2017-10-01)

Xpert MTB/RIF assay for diagnosis of extrapulmonary tuberculosis in children: a systematic review and meta-analysis
by: Young Seok Seo, et al.
Published: (2020-01-01)

Rolling out Xpert MTB/RIF® for tuberculosis detection in HIV-positive populations: An opportunity for systems strengthening
by: Ishani Pathmanathan, et al.
Published: (2017-03-01)

Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda
by: Ngabonziza, J.C.S., et al.
Published: (2021)

Role of empiric treatment in hospitalized patients with Xpert MTB/RIF-negative presumptive pulmonary tuberculosis: A prospective cohort study
by: Wakjira Kebede, et al.
Published: (2020-08-01)

The limitations of the Cepheid GeneXpert® Mtb/Rif assay for the diagnosis and management of polyresistant pulmonary tuberculosis
by: Dahlia Hopmeier, et al.
Published: (2020-10-01)

Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis
by: Kaican Zong, et al.
Published: (2019-08-01)

Apport du Test Xpert MTB/RIF dans le diagnostic et le traitement de la tuberculose.
by: HE Hassan, et al.
Published: (2021-06-01)

Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis
by: Asmaa Mohammed Elbrolosy, et al.
Published: (2021-05-01)

Evaluating the diagnostic accuracy of the Xpert MTB/RIF assay on bronchoalveolar lavage fluid: A retrospective study
by: Yanjun Lu, et al.
Published: (2018-06-01)

Spot specimen testing with GeneXpert MTB/RIF results compared to morning specimen in a programmatic setting in Cotonou, Benin
by: Faridath Massou, et al.
Published: (2021-09-01)

Performance of Xpert/MTB/RIF assay for childhood pulmonary tuberculosis among HIV negative children with real world evidence in China
by: Lu Xia, et al.
Published: (2020-11-01)

Oral swab testing by Xpert® MTB/RIF Ultra for mass tuberculosis screening in prisons
by: Fabiano Lima, et al.
Published: (2020-05-01)

Evaluation of Xpert MTB/RIF assay for rapid molecular diagnosis of tuberculosis in a two-year period in Croatia
by: Ljiljana Zmak, et al.
Published: (2013-01-01)

Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China
by: Zheyuan Wu, et al.
Published: (2020-02-01)

Evaluation of the geneXpert MTB/RIF assay for early diagnosis of tuberculosis and detection of rifampicin resistance in pulmonary and extrapulmonary specimens
by: Ali Albay, et al.
Published: (2016-09-01)

Use of the GenoType MTBDRplus for early diagnosis of multidrug-resistant tuberculosis
by: O. M. Raznatovska, et al.
Published: (2017-04-01)

Performance of Xpert® MTB/RIF in diagnosing tuberculous pleuritis using thoracoscopic pleural biopsy
by: Chengjun Li, et al.
Published: (2020-11-01)

Application value of tissue tuberculosis antigen combined with Xpert MTB/RIF detection in differential diagnoses of intestinal tuberculosis and Crohn’s disease
by: Baoying Fei, et al.
Published: (2021-05-01)

Clinical validation of urine-based Xpert® MTB/RIF assay for the diagnosis of urogenital tuberculosis: A systematic review and meta-analysis
by: Ke Chen, et al.
Published: (2020-06-01)

Impact of Larger Sputum Volume on Xpert® MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis
by: Sharlaa Badal-Faesen, et al.
Published: (2017-08-01)

Usefulness of Xpert MTB/RIF Ultra to Rapidly Diagnose Sputum Smear-Negative Pulmonary Tuberculosis Using Bronchial Washing Fluid
by: Jung-Yien Chien, et al.
Published: (2020-09-01)

Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis
by: Katherine Antel, et al.
Published: (2020-01-01)

Xpert® MTB/RIF assay on formalin-fixed paraffin-embedded tissues in the diagnosis of extrapulmonary tuberculosis
by: Allan N. Njau, et al.
Published: (2019-09-01)

Diagnostic Efficacy of Xpert MTB/RIF Assay in Bronchoalveolar Lavage Fluid for Tracheobronchial Tuberculosis: A Retrospective Analysis
by: Yue Sun, et al.
Published: (2021-08-01)